Seasoned investor and operating executive focused on growth-stage technology and financial-services businesses. Chris Kleine brings experience directing capital allocation, portfolio transformation, and strategic M&A while serving on boards and leading commercial scaling initiatives. He blends investment sourcing, due diligence, and hands-on operational improvement to drive EBITDA expansion and exit planning. Prior roles span investment management and senior operating functions; holds advanced business credentials and is active in deal syndication and limited partner networks. Market-relevant expertise includes growth equity, operational turnarounds, and governance oversight.
Seasoned investor and operating executive focused on growth-stage technology and financial-services businesses. Chris Kleine brings experience directing capital allocation, portfolio transformation, and strategic M&A while serving on boards and leading commercial scaling initiatives. He blends investment sourcing, due diligence, and hands-on operational improvement to drive EBITDA expansion and exit planning. Prior roles span investment management and senior operating functions; holds advanced business credentials and is active in deal syndication and limited partner networks. Market-relevant expertise includes growth equity, operational turnarounds, and governance oversight.
Focuses on growth-stage technology and financial-services companies, pursuing concentrated growth-equity investments where operational intervention accelerates value creation. Prioritizes rigorous due diligence, board-level governance, and disciplined capital allocation to catalyze EBITDA expansion through commercial scaling, margin improvement, and targeted M&A. Favors multi-year hold periods that balance active operational involvement with exit-driven value realization. Risk-managed portfolio construction combines selective syndication with hands-on turnaround playbooks, emphasizing scalable revenue models, repeatable unit economics, and clear governance milestones to de-risk exits.
Focuses on growth-stage technology and financial-services companies, pursuing concentrated growth-equity investments where operational intervention accelerates value creation. Prioritizes rigorous due diligence, board-level governance, and disciplined capital allocation to catalyze EBITDA expansion through commercial scaling, margin improvement, and targeted M&A. Favors multi-year hold periods that balance active operational involvement with exit-driven value realization. Risk-managed portfolio construction combines selective syndication with hands-on turnaround playbooks, emphasizing scalable revenue models, repeatable unit economics, and clear governance milestones to de-risk exits.
| Trades 552 | Longs Won 347/552 62% | Profit Factor 1.53 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $285,612.65 |
| Average Win $81,578.86 | Best Trade (Aug 28) $5.36M | Sharpe Ratio -13.22 |
| Average Loss -$90,142.95 | Worst Trade (Aug 10) -$3.16M | Z-Score 1.35 (82.21%) |
| Commissions $0 | Avg. Trade Length 8m 1w 2d | Expectancy $17,805.37 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.07% |
| Consecutive Losing Trades | 1,764 | 1,587 | 1,411 | 1,235 | 1,058 | 882 | 705 | 529 | 353 | 176 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 23,837 | $5.94M | $7.36M | - | $1.42M | 23.9% | -7.354% |
ABBV AbbVie Inc. | 1,046 | $244,138.29 | $262,483.24 | - | $18,344.95 | 7.51% | -2.513% |
ABEV Ambev S.A. | 10,276 | $30,006 | $31,958.36 | - | $1,952.36 | 6.51% | -0.321% |
ADAM Adamas Trust, Inc. | 22,500 | $188,336.14 | $204,075 | - | $15,738.86 | 8.36% | +1.454% |
AGNT eXp World Holdings Inc. | 25,539 | $138,166 | $103,432.95 | - | -$34,733.05 | -25.14% | +3.846% |
AHRT AMERICAN HEALTHCARE REIT INC | 34,771 | $206,909.45 | $242,006.16 | - | $35,096.71 | 16.96% | -1.416% |
AMAT Applied Materials, Inc. | 3,916 | $2.6M | $1.99M | - | -$614,084.65 | -23.6% | +1.176% |
AMCX AMC Networks Inc. | 18,087 | $170,922.15 | $202,574.4 | - | $31,652.25 | 18.52% | +15.345% |
AMD Advanced Micro Devices, Inc. | 4,655 | $2.7M | $2.22M | - | -$487,657.8 | -18.03% | -1.904% |
AMGN Amgen Inc. | 978 | $272,040.77 | $376,686.48 | - | $104,645.71 | 38.47% | -0.64% |
AMZN Amazon.com Inc | 4,471 | $965,283.7 | $1.21M | - | $248,950.44 | 25.79% | +15.321% |
ANET Arista Networks, Inc. | 3,734 | $544,081.17 | $673,426.94 | - | $129,345.77 | 23.77% | +5.456% |
ARI Apollo Commercial Real Estate Finance Inc. | 39,544 | $422,334 | $261,781.28 | - | -$160,552.72 | -38.02% | +1.846% |
ARM Arm Holdings plc American Depositary Receipt | 4,779 | $1.69M | $1.15M | - | -$549,011.49 | -32.4% | -0.766% |
ASML ASML Holding N.V. New York Registry Shares | 166 | $330,247 | $270,414 | - | -$59,833 | -18.12% | -1.359% |
ASX ASE Technology Holding Co., Ltd. Sponsored ADR | 5,249 | $236,835 | $184,607.33 | - | -$52,227.67 | -22.05% | +1.15% |
AVAH Aveanna Healthcare Holdings Inc. | 10,449 | $67,291.28 | $98,116.11 | - | $30,824.83 | 45.81% | -3.096% |
AVGO Broadcom Inc. | 2,613 | $714,786.12 | $1.02M | - | $302,402.52 | 42.31% | +0.371% |
AXP American Express Company | 1,049 | $311,775.59 | $352,726.25 | - | $40,950.66 | 13.13% | -0.376% |
BAC Bank of America Corporation | 9,804 | $432,099.06 | $607,357.8 | - | $175,258.74 | 40.56% | +0.356% |